Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Barrett

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Blood|July 29, 2009
Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responsesAlix E Seif, David M Barrett, Michael Milone, et al.
Cancer Immunology Research|August 9, 2014
Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastomaNathan Singh, Xiaojun Liu, Jessica Hulitt, et al.
Cytotherapy|May 17, 2017
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell functionNathan Singh, Ted J Hofmann, Zachary Gershenson, et al.
Pediatrics in Review|June 3, 2008
Index of suspicionDavid M Barrett, Christine S Cho, Nicolas Brown, et al.
Nature Communications|January 22, 2021
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastomaBabak Moghimi, Sakunthala Muthugounder, Samy Jambon, et al.
Human Gene Therapy|August 16, 2011
Treatment of advanced leukemia in mice with mRNA engineered T cellsDavid M Barrett, Yangbing Zhao, Xiaojun Liu, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial dataKelly Speth, Jin Xie, Qinghua Song, et al.
Blood|August 23, 2011
Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modelingDavid M Barrett, Alix E Seif, Carmine Carpenito, et al.
Oncoimmunology|March 5, 2016
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastomaNathan Singh, Irina Kulikovskaya, David M Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2018
CD3<sup>+</sup>/CD19<sup>+</sup> Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic DisordersJoseph H Oved, Yongping Wang, David M Barrett, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Blood|July 29, 2009
Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responsesAlix E Seif, David M Barrett, Michael Milone, et al.
Cancer Immunology Research|August 9, 2014
Nature of tumor control by permanently and transiently modified GD2 chimeric antigen receptor T cells in xenograft models of neuroblastomaNathan Singh, Xiaojun Liu, Jessica Hulitt, et al.
Cytotherapy|May 17, 2017
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell functionNathan Singh, Ted J Hofmann, Zachary Gershenson, et al.
Pediatrics in Review|June 3, 2008
Index of suspicionDavid M Barrett, Christine S Cho, Nicolas Brown, et al.
Nature Communications|January 22, 2021
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastomaBabak Moghimi, Sakunthala Muthugounder, Samy Jambon, et al.
Human Gene Therapy|August 16, 2011
Treatment of advanced leukemia in mice with mRNA engineered T cellsDavid M Barrett, Yangbing Zhao, Xiaojun Liu, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial dataKelly Speth, Jin Xie, Qinghua Song, et al.
Blood|August 23, 2011
Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modelingDavid M Barrett, Alix E Seif, Carmine Carpenito, et al.
Oncoimmunology|March 5, 2016
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastomaNathan Singh, Irina Kulikovskaya, David M Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2018
CD3<sup>+</sup>/CD19<sup>+</sup> Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic DisordersJoseph H Oved, Yongping Wang, David M Barrett, et al.
Pageof 8